A ceiling, reached at the first opportunity
Read the two documents in the order Oracle published them. On October 28, at its Investor Day, the company committed to limiting the additional funding it raises in the capital markets for its fiscal 2027 to 2030 investment cycle to $20 billion, expected to be $10 billion in equity and $10 billion in gross debt. The commitment was the reassuring part of the day: capital spending would peak this year and next, free cash flow would follow, and the market would not be asked for open-ended amounts in between. Shares rallied about 11% on Wednesday, according to Reuters.
On November 2, five days later, Oracle filed concurrent offerings for $10 billion of common stock and $10 billion of senior notes. The combined proposed amount matches the $20 billion commitment, and the announced equity-and-debt mix matches too. But a filing is not a completed raise. The offerings had not yet been priced, and the final share count, interest rates and tranche allocations were still to be determined. Oracle has put the entire stated allowance into the market at once; it has not yet demonstrated that the full amount will be raised.
There is a fair defense, and it is worth stating plainly. A cap is a ceiling, not a schedule. Raising the money early, while the company says capex is peaking, can be cheaper than returning to the market four times. Nothing in the October 28 commitment promised to spread the $20 billion out. What the speed changes is the commitment's function. Oracle has launched offerings matching the full stated allowance before the first week is over. But until the securities are priced, sold and their use of proceeds clarified, it is too early to say the cap has been exhausted. From here to fiscal 2030, the question is whether the final amount raised, particularly the portion of debt that is refinancing rather than additional funding, counts against the commitment as investors were led to understand it.
The clause that decides whether the cap was spent
That definition has a moving part. The October 28 commitment excludes refinancing of existing debt. So the stock half counts in full: $10 billion of new shares is the entire equity allowance. The notes are different. If none of the $10 billion refinances existing debt, the notes use the entire gross-debt allowance, and the full amount counts against the cap. If part of the notes repays old debt, that part sits outside the cap, and room remains.
The filings, as reported, do not settle it. Both offerings describe their proceeds as being for general corporate purposes, a category that can include capital spending, debt repayment, acquisitions, dividends and share buybacks. The documents therefore do not establish how much of the $10 billion in notes will fund additional investment and how much, if any, will refinance existing debt. That distinction matters: it determines how much of the debt offering counts against Oracle's four-year funding commitment. The public documents do not yet provide enough detail to calculate that amount.
The potential dilution can be estimated, but not fixed yet. The stock prospectus cites an October 30 last-sale price of $130.67. At that reference price, a $10 billion offering would represent approximately 76.5 million shares, or about 2.5% of the 3.02 billion shares outstanding as of August 31. The actual number will depend on the offering price and final terms. That would come on top of the $20 billion Oracle had already raised through its at-the-market program in Q1 FY27, which the October commitment explicitly places outside the new cap. Shareholders assessing the potential issuance should distinguish the completed earlier program from the newly proposed offering.
What the money has to carry
The raise lands on a balance sheet that is already working hard. Oracle carried $125.34 billion of notes payable and other borrowings at August 31, against $67.36 billion of revenue in fiscal 2026. The plan those borrowings support is large: revenue of $225 billion or more by fiscal 2030, growth of more than 35% a year compounded from fiscal 2026, capital spending peaking in fiscal 2027 and 2028, then stepping down, with at least $30 billion of positive free cash flow promised for fiscal 2029. Reuters also reports the CFO expects free cash flow to turn positive in the second half of fiscal 2028. Those are the company's own figures, and the raise should be read against them. The $20 billion is intended to bridge the investment cycle toward a period when Oracle expects positive free cash flow to support the business.
The market's first reading was not generous. Shares fell nearly 6% on Monday, on top of a decline of roughly 33% this year through Friday, and Oracle's long 6.85% bonds due 2066 fell more than a cent on the dollar. Part of that is arithmetic: more shares, more debt, same promises. Part of it is the question this piece started with. Investors were told on Wednesday that the ask had a limit. On Monday they learned the limit and the ask are the same size, and that whether the limit was actually reached depends on a refinancing line the filings do not fill in. The next document that matters is not another commitment. It is the final pricing, and after that, a statement of how much of the notes replaced old debt.
Sources
- [1] Oracle — Investor Day 2026 release, filed with the SEC as Exhibit 99.1, October 28, 2026 (total revenue of $225 billion or more in FY30 and growth of more than 35% CAGR from FY26 through FY30; peak capex in FY27–FY28, stepping down in FY29; positive free cash flow of at least $30 billion in FY29; commitment to limit additional funding to be raised in the capital markets for the FY27–FY30 investment cycle to $20 billion, currently expected to be $10 billion in equity and $10 billion in gross debt; the requirement excludes refinancing of existing debt; the commitment is in addition to the $20 billion at-the-market equity raise completed in the first quarter of fiscal 2027; FY27 outlook reaffirmed at total revenue of at least $90 billion and non-GAAP EPS of $8.10; read first-hand)Read source
- [2] Oracle — preliminary prospectus supplement (Form 424B5) for the $10 billion common stock offering, filed with the SEC November 2, 2026 (last reported sale price of $130.67 per share on the New York Stock Exchange on October 30, 2026; 3,023,726,695 shares of common stock outstanding as of August 31, 2026; the closing of the stock offering is not conditioned on the closing of the concurrent notes offering, and vice versa; net proceeds to be used for general corporate purposes, which may include capital expenditures, repayment of indebtedness, future investments or acquisitions and payment of cash dividends or share repurchases; read first-hand)Read source
- [3] Oracle — preliminary prospectus supplement (Form 424B2) for the $10 billion senior notes offering, filed with the SEC November 2, 2026 (six series: floating-rate notes due 2029 and fixed-rate notes due 2029, 2031, 2033, 2037 and 2046; net proceeds to be used for general corporate purposes, which may include capital expenditures, repayment of indebtedness, future investments or acquisitions and payment of cash dividends or share repurchases; read first-hand)Read source
- [4] Reuters — "Oracle taps investors for $20 billion to finance AI expansion," November 2, 2026, published 13:22 UTC, updated 15:49 UTC ($20 billion through bond and share sales per Monday's regulatory filings; shares fell nearly 6% intraday, extending a decline of roughly 33% this year through Friday, October 30; shares had rallied about 11% on Wednesday, October 28; proceeds for general corporate purposes including capital spending, debt repayment, acquisitions, dividends and buybacks; CFO Hilary Maxson expects free cash flow to turn positive in the second half of fiscal 2028; $125.34 billion of notes payable and other borrowings at August 31 against fiscal 2026 revenue of $67.36 billion; six bond tranches maturing 2029–2046, one floating-rate and five fixed-rate, with rates, prices and share count not yet set; the 6.85% bonds due 2066 fell more than 1.2 cents on the dollar, per Tradeweb; read in full via syndication)Read source